Comparing Linzess vs Relistor
Linzess (linaclotide) | Relistor (methylnaltrexone) |
|
---|
Linzess (linaclotide) | Relistor (methylnaltrexone) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Chronic Idiopathic Constipation, Irritable Bowel Syndrome with Constipation, Functional Constipation, Irritable Bowel Syndrome. Linzess may also be used for purposes not listed in this... View more |
Prescription only
Prescribed for Opioid-Induced Constipation, Constipation - Chronic, Constipation - Drug Induced. Relistor may also be used for purposes not listed in this medication guide. |
||||||||||||||||
More about Linzess (linaclotide) | More about Relistor (methylnaltrexone) | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Linzess has an average rating of 6.7 out of 10 from a total of 885 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 26% reported a negative effect. |
Relistor has an average rating of 6.6 out of 10 from a total of 61 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 31% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Linzess side effects |
View all Relistor side effects |
||||||||||||||||
Drug Class | |||||||||||||||||
Generic Availability | |||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Linzess prices |
View all Relistor prices |
||||||||||||||||
Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
N/A |
8 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 59 drugs are known to interact with Linzess:
|
A total of 24 drugs are known to interact with Relistor:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
August 30, 2012 |
April 24, 2008 |
||||||||||||||||
WADA Class View classifications | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient Resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
MiraLAX
MiraLAX (polyethylene glycol) is used as a laxative to treat occasional constipation or irregular ...
Bentyl
Bentyl is used to treat functional bowel or irritable bowel syndrome. Bentyl may also be used for ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Xifaxan
Xifaxan (rifaximin) is used to treat travelers' diarrhea, irritable bowel syndrome with diarrhea ...
Metamucil
Metamucil is used for constipation, dietary fiber supplementation, irritable bowel syndrome
Amitiza
Amitiza (lubiprostone) is used to treat chronic constipation and irritable bowel syndrome with ...
Trulance
Trulance (plecanatide) is used to treat chronic idiopathic constipation (CIC) and irritable bowel ...
Levsin
Levsin is used to treat stomach problems such as cramps and irritable bowel syndrome and conditions ...
Motegrity
Motegrity (prucalopride) is used to treat chronic idiopathic constipation. Motegrity information ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.